Victrex plc (LON:VCT)
London · Delayed Price · Currency is GBP · Price in GBX 690.00
+3.00 (0.44%)
Aug 1, 2025, 4:35 PM BST
Revance Therapeutics Market Cap
Victrex has a market cap or net worth of 600.14 million as of August 1, 2025. Its market cap has decreased by -37.26% in one year.
Market Cap
600.14M
Enterprise Value
639.84M
Revenue
297.60M
Ranking
n/a
PE Ratio
20.23
Stock Price
$690.00
Market Cap Chart
Since July 28, 1997, Victrex's market cap has increased from 134.59M to 600.14M, an increase of 345.90%. That is a compound annual growth rate of 5.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2025 | 597.53M | -36.14% |
| Dec 31, 2024 | 935.68M | -29.28% |
| Dec 29, 2023 | 1.32B | -4.66% |
| Dec 30, 2022 | 1.39B | -34.63% |
| Dec 31, 2021 | 2.12B | 4.61% |
| Dec 31, 2020 | 2.03B | -5.77% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Rio Tinto Group | 78.40B |
| Glencore | 36.38B |
| Anglo American | 24.08B |
| Antofagasta | 19.66B |
| Fresnillo | 10.54B |
| Mondi | 5.15B |
| Croda International | 3.63B |
| Johnson Matthey | 2.97B |